Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy

Journal of Immunotherapy

Volumn 34, Issue 4, 2011, Pages 397-402

  Langan, Russell C ^a   Prieto, Peter A ^a   Sherry, Richard M ^a   Zlott, Daniel ^a   Wunderlich, John ^a   Csako, Gyorgy ^b   Costello, Rene ^b   White, Donald E ^a   Rosenberg, Steven A ^a   Yang, James C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

cyclophosphamide; follicle stimulating hormone; ovarian recovery; ovarian toxicity; premature ovarian failure

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; FLUDARABINE; FOLLITROPIN; IFOSFAMIDE; INTERLEUKIN 2; TEMOZOLOMIDE; THALIDOMIDE; VINBLASTINE; VINBLASTINE SULFATE;

ADOPTIVE CELL THERAPY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CELL THERAPY; CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLITROPIN BLOOD LEVEL; GONAD DYSFUNCTION; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL RECORD REVIEW; MELANOMA; MENSTRUATION; OVARY FUNCTION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; RADIATION DOSE; SARCOMA; WHOLE BODY RADIATION;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MIDDLE AGED; NEOPLASMS; OVARY; PRIMARY OVARIAN INSUFFICIENCY; RADIOTHERAPY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VIDARABINE; YOUNG ADULT;

EID: 79955611759     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e3182187508     Document Type: Article

References (16)

1. Tempone A. Ovarian function preservation in patients under chemotherapy treatment. Gynecol Endocrinol. 2008;24:481-482.
2. Schimmer A, Quatermain M, Imrie K, et al. Ovarian Function After Autologous Bone Marrow Transplantation. J Clin Oncol. 1998;16:2359-2363. (Pubitemid 28309028)
3. Koyama H, Wada T, Nishizawa Y, et al. Cyclophosphamideinduced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer. 1977;39:1403-1409. (Pubitemid 8108291)
4. Katsifis GE, Tzioufas AG. Ovarian Failure in systemic lupus erythematous patients treated with pulsed intravenous cyclophosphamide. Lupus. 2004;13:673-678. (Pubitemid 39279782)
5. Green D, Sklar C, Boice J, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2374-2381.
6. Fong S, Laven JSE, Hakvoort-Cammel FGAJ, et al. Assessment of ovarian reserve in adult childhood cancer survivors using anti- Mullerian hormone. Human Reprod. 2009;24:982-990.
7. Sklar C. Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monographs. 2005;34:25-27.
8. Maneschi F, Benedetti-Panici P, Scambia G, et al. Menstrual and hormone patterns in women treated with high-dose cisplatin and bleomycin. Gynecol Oncol. 1994;54:345-348. (Pubitemid 24301911)
9. Williams D, Crofton PM, Levitt G. Does Ifosfamide Affect Gonadal Function? Pediatr Blood Cancer. 2008;50:347-351.
10. Giuseppe L, Attilio G, Edoardo DN, et al. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology. 2007;12:141-147. (Pubitemid 46605523)
11. Gompel A, Frances C, Piette JC, et al. Ovarian failure with thalidomide treatment in complex aphthosis: comment on the concise communication by Ordi et al. Arthr Rheum. 1999;42: 2255-2260.
12. Dudley ME, Wunderlich JR, Yang JC, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol. 2005;23:2346.
13. Dudley ME, Yang JC, Sherry R, et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol. 2008;26:5233.
14. Sanders J, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87:3045-3052.
15. Liu J, Malhotra R, Voltarelli J, et al. Ovarian recovery after stem cell transplantation. Bone Marrow Transplant. 2008;41: 275-278. (Pubitemid 351260382)
16. Clowse M, Behera M, Anders C, et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Women Health. 2009;18:311-319.